The struggling pharmacy chain has already provided some clues to which parts of the business a new owner may want off the ...

Here are five recent private equity deals, finalized or rumored, that ASCs are eyeing: ...

Looking to 2025, Peluchiwski’s group forecasts that industrials dealflow will increase 20-25 percent in the year ahead, as the active buyer-to-seller ratio to quality assets remains high, while ...

Walgreens has slipped behind CVS because it’s smaller than CVS, giving it less scale to negotiate prices with insurers and ...

In a deal that could value the chain at $10 billion, the discussions mark a potential shift for the 175-year-old brand ...

Private equity-linked healthcare transactions are poised to rebound as interest rates cool and a new presidential administration takes over.

If Walgreens Boots Alliance follows through with a sale to private equity, the company might join other healthcare deals ...

Walgreens Boots Alliance is considering selling the company to a private equity firm — a move that would take the publicly traded company private, according to a Wall Street Journal report.

Albertsons, in its announcement terminating the agreement, also said it had authorized a $2 billion stock buyback and hiked its quarterly cash dividend by 25%. The chain's biggest shareholder, ...

Walgreens has struggled lately due to declining prescription reimbursements and rising competition from Amazon and other ...